NCT01787409 - Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency | Biotech Hunter

Enrollment

565

Participants

Timeline

Start Date

March 6, 2013

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions

Aggressive Non-Hodgkin LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-Cell LymphomaChronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaEnteropathy-Associated T-Cell LymphomaHepatosplenic T-Cell LymphomaMature T-Cell and NK-Cell Non-Hodgkin LymphomaMediastinal (Thymic) Large B-Cell LymphomaNasal Type Extranodal NK/T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedPrimary Cutaneous Anaplastic Large Cell LymphomaRefractory Anaplastic Large Cell LymphomaSmall Lymphocytic LymphomaSubcutaneous Panniculitis-Like T-Cell Lymphoma

Interventions

DIETARY_SUPPLEMENT

Cholecalciferol

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (5)

30322

Emory University/Winship Cancer Institute, Atlanta

52242

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

55905

Mayo Clinic, Rochester

63110

Washington University School of Medicine, St Louis

85259

Mayo Clinic in Arizona, Scottsdale